WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are... disappearing, but other serogroups (e.g. NmW, NmX and NmC) still cause epidemics, albeit at a lower frequency and of a smaller size. Due to these changes, WHO organized the review of the evidence to provide recommendations for epidemic control, related to operational thresholds for investigation and response to outbreaks, the use of rapid diagnostic tests, antibiotic regimens in epidemics, and prophylaxis for household contacts of cases
more
Report for WHO Meningitis guideline revision
Dr Thomas Waite, April 2014
Field Epidemiology Services, Public Health England; UK
Anxiety Disorders
Chapter F.4
Received: 16/11/2013 - Accepted: 23/03/2014 - Published: 27/07/2014
MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206
Towards attaining the highest standard Health.
Developmental disorders
Chapter C.2
2014 Edition
Psychiatry and Pediatrics
Chapter I.4
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
« Programme Renforcement et Décentralisation de la Prévention et de
la prise en charge des PVVIH en RCA »